Skip to content
The Policy VaultThe Policy Vault

Pliaglis (lidocaine 7%/tetracaine cream 7%) — Blue Cross Blue Shield of New Mexico

Stage four advanced, metastatic cancer or associated condition when consistent with best practices and supported by peer-reviewed evidence

Initial criteria

  • The requested agent will be used for one of the listed indications AND
  • The patient does NOT have any FDA labeled contraindications to the requested agent
  • If applicable, chart notes are required as indicated in criteria

Approval duration

12 months